Orion
Su Nguyen has extensive experience in the field of biopharmacy and biochemistry, currently serving as the Preclinical Safety Lead and Senior Scientist at Orion Corporation since April 2019. Prior to this role, Su worked at the Wihuri Research Institute as a Senior Researcher from September 2010 to April 2019. Su's academic journey includes a postdoctoral researcher position at the University of Pennsylvania from March 2009 to August 2010 and a postdoctoral fellowship at KU Leuven from September 2006 to December 2008. Su obtained a Docent degree in Biochemistry from the University of Helsinki between 2011 and 2017 and completed a PhD in Industrial Biopharmacy at Chungnam National University from 2001 to 2006.
This person is not in any teams
This person is not in any offices
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.